Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
FTSE 100 movers: Pharmaceuticals rally; gambling stocks slump again
(Sharecast News) - London's FTSE 100 was 0.8% higher at 9,428.80 in afternoon trade on Wednesday. Pharmaceuticals were the standout gainers, with AstraZeneca, Hikma and GSK all sharply higher after Pfizer struck a deal with US President Donald Trump to cut US drug prices.
As part of the deal, in exchange for Pfizer committing to a $70bn investment in manufacturing and research in the US, it will be exempt from pharmaceutical tariffs for three years.
Trump announced plans on Tuesday to launch a government-run website, dubbed TrumpRx, for consumers to buy drugs directly from manufacturers.
Kathleen Brooks, research director at XTB, said: "Tariffs is the theme that won't go away, and when the tariff news is positive, this is good for the FTSE 100 due to its international flavour. Thus, signs that President Trump is willing to forego tariff revenue for domestic pricing deals, is seen as positive for the sector.
"The Pfizer news highlights the transactional nature of the President's tariff policies. Even though he threatened 100% tariffs on pharma imports last week, the Pfizer news shows that deals can still be made.
"Added to this, the US has unveiled a new drug buying site, TrumpRX, which has also excited investors. It is difficult to see how this new website will impact pharma company revenues, and we think that the tariff reprieve for Pfizer will have a longer-term impact on the pharma sector."
JD Sports was also in the black after Nike's first-quarter earnings beat expectations.
On the downside, Flutter Entertainment and Ladbrokes owner Entain fell again, having slumped on Tuesday after Chancellor Reeves hinted in an interview with ITV News that she could announce tax rises for the sector in the November budget.
FTSE 100 - Risers
AstraZeneca (AZN) 11,962.00p 7.17% Hikma Pharmaceuticals (HIK) 1,777.00p 4.89% JD Sports Fashion (JD.) 99.54p 4.55% GSK (GSK) 1,623.00p 3.27% Intertek Group (ITRK) 4,816.00p 2.12% Croda International (CRDA) 2,748.00p 1.81% Diageo (DGE) 1,806.00p 1.80% London Stock Exchange Group (LSEG) 8,648.00p 1.55% Spirax Group (SPX) 6,895.00p 1.47% Pearson (PSON) 1,071.00p 1.42%
FTSE 100 - Fallers
Babcock International Group (BAB) 1,287.00p -3.23% Flutter Entertainment (DI) (FLTR) 18,955.00p -2.22% Coca-Cola HBC AG (CDI) (CCH) 3,430.00p -2.17% Tesco (TSCO) 436.20p -2.04% Imperial Brands (IMB) 3,096.00p -2.03% BAE Systems (BA.) 2,023.00p -1.75% Auto Trader Group (AUTO) 776.80p -1.62% Entain (ENT) 861.40p -1.46% Pershing Square Holdings Ltd NPV (PSH) 4,554.00p -1.43% Rolls-Royce Holdings (RR.) 1,176.50p -1.18%
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
